Dr. Damian Laber, MD

NPI: 1922089747
Total Payments
$1.4M
2024 Payments
$17,369
Companies
21
Transactions
1,509
Medicare Patients
1,105
Medicare Billing
$233,259

Payment Breakdown by Category

Other$1.1M (79.0%)
Travel$196,711 (13.7%)
Consulting$69,409 (4.8%)
Food & Beverage$33,997 (2.4%)
Education$2,820 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1.0M 335 72.3%
Travel and Lodging $196,711 563 13.7%
Honoraria $95,414 36 6.6%
Consulting Fee $69,409 30 4.8%
Food and Beverage $33,997 473 2.4%
Education $2,820 72 0.2%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $494,518 366 $0 (2019)
Alexion Pharmaceuticals, Inc. $419,068 607 $0 (2024)
Genentech USA, Inc. $117,063 100 $0 (2021)
GENZYME CORPORATION $93,371 58 $0 (2023)
Lilly USA, LLC $78,864 137 $0 (2022)
Ipsen Biopharmaceuticals, Inc $69,895 39 $0 (2023)
CSL Behring $57,130 56 $0 (2019)
Regeneron Healthcare Solutions, Inc. $50,213 49 $0 (2019)
Apellis Pharmaceuticals, Inc. $35,188 49 $0 (2022)
PORTOLA PHARMACEUTICALS, INC. $12,071 18 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $17,369 16 Alexion Pharmaceuticals, Inc. ($14,674)
2023 $24,884 16 Alexion Pharmaceuticals, Inc. ($19,037)
2022 $134,222 139 Alexion Pharmaceuticals, Inc. ($65,604)
2021 $84,029 70 Alexion Pharmaceuticals, Inc. ($42,907)
2020 $45,978 59 Alexion Pharmaceuticals, Inc. ($30,244)
2019 $443,005 414 E.R. Squibb & Sons, L.L.C. ($145,087)
2018 $346,273 386 E.R. Squibb & Sons, L.L.C. ($169,585)
2017 $344,111 409 E.R. Squibb & Sons, L.L.C. ($179,845)

All Payment Transactions

1,509 individual payment records from CMS Open Payments — Page 1 of 61

Date Company Product Nature Form Amount Type
12/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,590.00 General
11/25/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $125.62 General
Category: Rare Disease
10/18/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $104.59 General
06/24/2024 Alexion Pharmaceuticals, Inc. SOLIRIS (Biological) Education In-kind items and services $93.95 General
Category: Rare Disease
03/02/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $48.00 General
03/01/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $667.20 General
03/01/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $371.77 General
03/01/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $176.37 General
03/01/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $74.73 General
03/01/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $54.80 General
03/01/2024 Alexion Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $31.32 General
03/01/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $10.00 General
02/29/2024 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $12,870.00 General
02/29/2024 Alexion Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $98.30 General
02/29/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $43.80 General
02/29/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $8.20 General
10/05/2023 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $10,920.00 General
10/03/2023 Alexion Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $33.93 General
10/03/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $27.12 General
09/15/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $30.00 General
09/15/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $25.57 General
09/14/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $317.96 General
09/14/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $299.15 General
09/14/2023 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $147.53 General
06/27/2023 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $123.33 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 228 438 $111,035 $47,403
2022 4 256 458 $121,123 $51,858
2021 4 290 552 $138,891 $60,529
2020 5 331 713 $176,850 $73,470
Total Patients
1,105
Total Services
2,161
Medicare Billing
$233,259
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 69 199 $47,622 $21,358 44.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 68 145 $31,154 $13,975 44.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 44 45 $18,174 $6,258 34.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 33 33 $11,275 $4,843 43.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 16 $2,810 $969.06 34.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 62 155 $35,084 $17,408 49.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 94 102 $40,596 $16,125 39.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 65 162 $34,344 $13,221 38.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 23 23 $7,488 $3,345 44.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 12 16 $3,611 $1,759 48.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 112 120 $47,760 $18,862 39.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 79 219 $46,428 $18,203 39.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 47 125 $27,075 $14,829 54.8%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 32 67 $14,415 $7,343 50.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 20 21 $3,213 $1,291 40.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 106 314 $67,510 $28,420 42.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 82 244 $51,728 $20,882 40.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 111 121 $48,158 $20,142 41.8%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 20 20 $6,500 $2,793 43.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 12 14 $2,954 $1,234 41.8%

About Dr. Damian Laber, MD

Dr. Damian Laber, MD is a Hematology & Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922089747.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damian Laber, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $17,369 received in 2024. These payments were reported across 1,509 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).

As a Medicare-enrolled provider, Laber has provided services to 1,105 Medicare beneficiaries, totaling 2,161 services with total Medicare billing of $233,259. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Tampa, FL
  • Active Since 11/09/2005
  • Last Updated 11/03/2025
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1922089747

Products in Payments

  • OPDIVO (Biological) $322,963
  • EMPLICITI (Biological) $171,555
  • SOLIRIS (Drug) $146,014
  • GAZYVA (Biological) $77,261
  • LIBTAYO (Drug) $71,822
  • CYRAMZA (Drug) $65,451
  • ONIVYDE (Drug) $59,798
  • LIBTAYO (Biological) $44,564
  • Ultomiris (Drug) $40,049
  • ULTOMIRIS (Biological) $35,071
  • Empaveli (Drug) $33,418
  • ULTOMIRIS (Drug) $28,560
  • Multiple Products (Biological) $21,030
  • Idelvion (Biological) $19,188
  • Afstyla (Biological) $16,787
  • JEVTANA (Drug) $15,733
  • TECENTRIQ (Biological) $13,136
  • BEVYXXA (Drug) $12,071
  • Rituxan (Biological) $9,689
  • SOMATULINE DEPOT (Drug) $7,395

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Tampa